149 related articles for article (PubMed ID: 27379703)
41. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
[TBL] [Abstract][Full Text] [Related]
42. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
43. Absence of EZH2 gene mutation in chronic myeloid leukemia patients in blast crisis.
Chen HY; Yao H; Wu LY; Liu CJ; Zhu JQ; Liu CH; Wang W; Dong SS; Ping NN; Chen SN; Sun M
Asian Pac J Cancer Prev; 2013; 14(5):3375-6. PubMed ID: 23803132
[No Abstract] [Full Text] [Related]
44. Extramedullary pleural blast crisis in chronic myelogenous leukemia: cytogenetic and molecular study.
Sacchi S; Temperani P; Selleri L; Zucchini P; Morselli S; Vecchi A; Longo R; Torelli G; Emilia G; Torelli U
Acta Haematol; 1990; 83(4):198-202. PubMed ID: 2115717
[TBL] [Abstract][Full Text] [Related]
45. Karyotypic changes during the course of blastic crisis of chronic myelogenous leukemia.
Mitani K; Miyazono K; Urabe A; Takaku F
Cancer Genet Cytogenet; 1989 Jun; 39(2):299-300. PubMed ID: 2752380
[No Abstract] [Full Text] [Related]
46. Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation.
Sazawal S; Singh K; Chhikara S; Chaubey R; Mishra P; Seth T; Saxena R
Indian J Cancer; 2020; 57(3):343-345. PubMed ID: 32769290
[No Abstract] [Full Text] [Related]
47. Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia.
Bose S; Goldman JM; Melo JV
Leukemia; 1999 Nov; 13(11):1894-6. PubMed ID: 10557068
[No Abstract] [Full Text] [Related]
48. [Bone marrow chromosomes in 172 patients with chronic myeloid leukemia].
Michalová K; Musilová J; Jarosová M; Indrák K; Koudelová Z
Vnitr Lek; 1988 Jul; 34(7):694-700. PubMed ID: 3176359
[No Abstract] [Full Text] [Related]
49. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
50. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Chen Z; Wang W; Cortes JE; Liu E; Miranda RN; Zhao C; Yuan J; Lu X; Yang W; Ameri MD; Kantarjian HM; Medeiros LJ; Hu S
Blood Cancer J; 2016 May; 6(5):e418. PubMed ID: 27152845
[No Abstract] [Full Text] [Related]
51. Variant (3;21) translocation and megakaryocytic involvement in blastic crisis of Philadelphia positive chronic myeloid leukaemia.
Aventin A; Mecucci C; Van Orshoven A; Delannoy A; Van den Berghe H
Br J Haematol; 1989 Apr; 71(4):562-4. PubMed ID: 2713276
[No Abstract] [Full Text] [Related]
52. Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve Infiltration.
Mbekeani JN; Abdel Fattah M; Al Nounou RM; Chebbo W; Dogar MA
J Neuroophthalmol; 2016 Mar; 36(1):73-7. PubMed ID: 26628337
[TBL] [Abstract][Full Text] [Related]
53. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
[TBL] [Abstract][Full Text] [Related]
54. Coexistence of translocation(1,19) and the Philadelphia chromosome in a child's first presentation of chronic myeloid leukemia in blast crisis treated with dasatinib.
Eckardt MA; Chang VY; Rao NP; Federman N
Pediatr Hematol Oncol; 2011 Nov; 28(8):669-75. PubMed ID: 22023462
[TBL] [Abstract][Full Text] [Related]
55. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
56. Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
Koh Y; Kim I; Yoon SS; Kim BK; Kim DY; Lee JH; Lee KH; Park E; Kim HJ; Sohn SK; Joo YD; Kim SJ; Chung J; Shin HJ; Kim SH; Kim CS; Song HS; Kim MK; Hyun MS; Ahn JS; Jung CW; Park S;
Ann Hematol; 2010 Jul; 89(7):725-31. PubMed ID: 20179930
[TBL] [Abstract][Full Text] [Related]
57. Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience.
Moschovi M; Adamaki M; Athanasiadou A; Divane A; Karytianou A; Tourkantoni N
Leuk Lymphoma; 2015; 56(8):2460-2. PubMed ID: 25641431
[No Abstract] [Full Text] [Related]
58. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
[TBL] [Abstract][Full Text] [Related]
59. [Chromosome aberrations in chronic myeloid leukemia].
Haus O
Acta Haematol Pol; 1992; 23(2 Suppl 1):5-12. PubMed ID: 1488873
[TBL] [Abstract][Full Text] [Related]
60. Biphenotypic extramedullary blast crisis with MLL gene rearrangement in a case of chronic myeloid leukemia following Dasatinib therapy: An unusual case.
Juneja R; Dhamija G; Dadu T; Handoo A
Indian J Pathol Microbiol; 2016; 59(2):259-60. PubMed ID: 27166066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
